Milestone Pharmaceuticals (MIST) Capital Expenditures (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Capital Expenditures of $45000.0 for Q1 2026, down 84.1% on a QoQ basis from $283000.0 in Q4 2025, and up 650.0% year-over-year from $6000.0 in Q1 2025.
Milestone Pharmaceuticals (MIST) Capital Expenditures (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Capital Expenditures history runs 7 years deep, the most recent figure standing at $45000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 650.0% year-over-year to $45000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $341000.0 (up 441.27% YoY) and the FY2025 annual result came in at $302000.0, up 815.15% from the prior year.
- Capital Expenditures was $45000.0 for Q1 2026 at Milestone Pharmaceuticals, down from $283000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $283000.0 in Q4 2025 and bottomed at $2000.0 in Q3 2025.
- A 5-year average of $53692.3 and a median of $31000.0 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures slumped 82.52% — and 2025, when it surged 1186.36%.
- Milestone Pharmaceuticals' Capital Expenditures stood at $110000.0 in 2022, then plunged by 71.82% to $31000.0 in 2023, then retreated by 29.03% to $22000.0 in 2024, then jumped by 1186.36% to $283000.0 in 2025, then slumped by 84.1% to $45000.0 in 2026.
- Business Quant data shows MIST's Capital Expenditures at $45000.0 in Q1 2026, $283000.0 in Q4 2025, and $2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45,000.00 |
| Mar 31, 2026 | 45,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 31,000.00 |